
Panchsheel Organics (PANCHSHEEL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
277.0M
Gross Profit
92.8M
33.51%
Operating Income
29.8M
10.76%
Net Income
29.1M
10.51%
Balance Sheet Metrics
Total Assets
1.6B
Total Liabilities
294.2M
Shareholders Equity
1.3B
Debt to Equity
0.22
Cash Flow Metrics
Revenue & Profitability Trend
Panchsheel Organics Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.1B | 1.1B | 1.0B | 690.2M | 490.1M |
Cost of Goods Sold | 691.6M | 698.6M | 666.8M | 399.2M | 287.3M |
Gross Profit | 380.2M | 353.4M | 360.0M | 291.0M | 202.8M |
Gross Margin % | 35.5% | 33.6% | 35.1% | 42.2% | 41.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 14.5M | 14.1M | 8.2M | 9.0M |
Other Operating Expenses | 124.8M | 81.8M | 90.8M | 102.8M | 60.7M |
Total Operating Expenses | 124.8M | 96.3M | 104.9M | 111.0M | 69.7M |
Operating Income | 154.0M | 172.2M | 182.8M | 116.0M | 78.6M |
Operating Margin % | 14.4% | 16.4% | 17.8% | 16.8% | 16.0% |
Non-Operating Items | |||||
Interest Income | - | 24.6M | 11.8M | 781.0K | 1.2M |
Interest Expense | 3.7M | 898.0K | 1.8M | 521.0K | 2.1M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 181.0M | 193.9M | 190.7M | 114.0M | 72.9M |
Income Tax | 43.0M | 52.8M | 50.0M | 30.4M | 22.9M |
Effective Tax Rate % | 23.8% | 27.2% | 26.2% | 26.7% | 31.4% |
Net Income | 137.9M | 141.1M | 140.7M | 83.6M | 50.1M |
Net Margin % | 12.9% | 13.4% | 13.7% | 12.1% | 10.2% |
Key Metrics | |||||
EBITDA | 206.7M | 212.4M | 207.0M | 127.1M | 89.9M |
EPS (Basic) | ₹10.47 | ₹11.88 | ₹12.78 | ₹8.33 | ₹9.98 |
EPS (Diluted) | ₹10.47 | ₹10.71 | ₹11.94 | ₹8.33 | ₹9.98 |
Basic Shares Outstanding | 13175263 | 11877000 | 11009000 | 10031000 | 5015000 |
Diluted Shares Outstanding | 13175263 | 11877000 | 11009000 | 10031000 | 5015000 |
Income Statement Trend
Panchsheel Organics Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 41.5M | 218.5M | 33.6M | 18.7M | 42.4M |
Short-term Investments | 2.6M | 2.4M | 2.4M | 871.0K | 1.1M |
Accounts Receivable | 348.0M | 394.7M | 387.9M | 325.2M | 189.8M |
Inventory | 459.0M | 395.2M | 324.4M | 252.6M | 187.9M |
Other Current Assets | 34.4M | 13.1M | 10.2M | 7.6M | 7.5M |
Total Current Assets | 887.3M | 1.0B | 761.8M | 607.7M | 430.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 179.0M | 12.6M | 8.0M | 5.4M | 5.2M |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 49.9M | -1.0K | 2.0K | 35.1M | 40.7M |
Total Non-Current Assets | 745.5M | 563.1M | 465.1M | 131.4M | 148.7M |
Total Assets | 1.6B | 1.6B | 1.2B | 739.1M | 578.6M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 163.9M | 213.3M | 158.8M | 168.2M | 115.6M |
Short-term Debt | 52.6M | 60.4M | 50.4M | 31.2M | 27.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 4.4M | 1.0K | 5.8M | 1.8M | 657.0K |
Total Current Liabilities | 242.8M | 294.8M | 236.8M | 224.6M | 158.5M |
Non-Current Liabilities | |||||
Long-term Debt | 1.8M | 2.7M | 5.4M | 9.9M | 10.3M |
Deferred Tax Liabilities | 0 | - | 0 | 0 | - |
Other Non-Current Liabilities | 2.0K | -1.0K | 6.1M | - | - |
Total Non-Current Liabilities | 51.4M | 45.4M | 29.4M | 40.4M | 23.3M |
Total Liabilities | 294.2M | 340.2M | 266.2M | 265.0M | 181.8M |
Equity | |||||
Common Stock | 131.7M | 131.7M | 117.8M | 100.3M | 50.2M |
Retained Earnings | - | 549.7M | 450.9M | 348.7M | 321.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.3B | 1.3B | 960.6M | 474.1M | 396.8M |
Key Metrics | |||||
Total Debt | 54.4M | 63.1M | 55.8M | 41.1M | 37.6M |
Working Capital | 644.5M | 732.7M | 524.9M | 383.1M | 271.4M |
Balance Sheet Composition
Panchsheel Organics Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 181.0M | 193.9M | 190.7M | 114.0M | 72.9M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -43.6M | -110.9M | -122.4M | -194.2M | -41.0M |
Operating Cash Flow | 110.4M | 61.1M | 62.0M | -78.1M | 35.1M |
Investing Activities | |||||
Capital Expenditures | -155.6M | -98.9M | -39.5M | -15.3M | -17.9M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -69.0M | -30.6M | -316.0M | - | - |
Investment Sales | 30.6M | 32.8M | - | - | - |
Investing Cash Flow | -194.0M | -96.7M | -355.5M | -15.3M | -17.9M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -39.6M | -35.3M | -35.3M | -6.7M | -6.4M |
Debt Issuance | - | - | - | - | 9.9M |
Debt Repayment | -8.7M | -2.7M | -4.5M | -359.0K | -14.1M |
Financing Cash Flow | -56.1M | 163.0M | 363.7M | -3.1M | -24.8M |
Free Cash Flow | -117.2M | -3.2M | -39.1M | -32.8M | 31.1M |
Net Change in Cash | -139.6M | 127.3M | 70.2M | -96.5M | -7.6M |
Cash Flow Trend
Panchsheel Organics Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.40
Price to Book
1.69
Price to Sales
2.11
PEG Ratio
-1.38
Profitability Ratios
Profit Margin
12.87%
Operating Margin
15.04%
Return on Equity
10.66%
Return on Assets
5.97%
Financial Health
Current Ratio
3.66
Debt to Equity
4.06
Beta
-0.17
Per Share Data
EPS (TTM)
₹10.47
Book Value per Share
₹101.73
Revenue per Share
₹81.35
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
panchsheel | 2.3B | 16.40 | 1.69 | 10.66% | 12.87% | 4.06 |
Sun Pharmaceutical | 3.8T | 36.65 | 5.28 | 15.08% | 19.29% | 3.26 |
Divi's Laboratories | 1.6T | 69.41 | 10.69 | 14.64% | 23.89% | 0.03 |
Sun Pharma Advanced | 46.4B | -13.50 | -21.28 | 157.88% | -53.22% | -1.24 |
Aarti Drugs | 44.7B | 23.70 | 3.27 | 12.28% | 7.80% | 44.92 |
Sequent Scientific | 43.5B | 202.31 | 6.17 | 4.35% | 1.41% | 62.47 |
Financial data is updated regularly. All figures are in the company's reporting currency.